A notable advancement in diabetes care is emerging with the introduction of tirzepatide at a dosage of 45mg. This innovative offering builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://funny-lists.com/story22680067/revolutionary-introduction-tirzepatide-dose-for-blood-sugar-control